| 3 months evaluation N = 74 | Evaluation after end of adjuvant treatment N = 74 | Statistical significance# | ||
Improvement | Deterioration | Improvement | Deterioration | P value* | |
No (%) | No (%) | No (%) | No (%) |
| |
Breast size | 11 (14.9) | 3 (4.1) | 12 (16.2) | 2 (2.7) | 0.018 |
Breast shape | 15 (20.3) | 3 (4.1) | 15 (20.3) | 2 (2.7) | 0.002 |
Scar visibility | 11 (14.9) | 2 (2.7) | 10 (13.5) | 2 (2.7) | 0.021 |
Nipple position | 10 (13.5) | 1 (1.35) | 10 (13.5) | Zero (0) | 0.002 |
Skin color | 5 (6.8) | 1 (1.35) | 4 (5.4) | Zero (0) | 0.046 |
Donor site | 74 (100) | Zero (0) | 74 (100) | Zero (0) | <0.001 |